0      0

AONN+ Annual 2020


SAT10 - Breakout Session 7 | Navigating Unknown Primary Cancer


Nov 7, 2020 2:15pm ‐ Nov 7, 2020 3:15pm

Description

The American Cancer Society estimates that between 2% and 5% of patient who have been diagnosed with metastatic cancer however the primary site can’t be located. This session will discuss how clinical decisions are made when a primary cancer site cannot be diagnosed.

Learning Objectives:
  • The learner will be able to state three reasons why a primary site can’t be located.
  • The learner will be able to state the largest pathological type of cancer from an unknown primary
  • The learner will be able to state the treatment options for cancers with an unknown primary.

Speaker(s):

  • Emma E. Furth, MD, Professor of Pathology and Laboratory Medicine, Hospital at the University of Pennsylvania

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content